Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Response Oncology, Inc. (OTC BB:ROIX.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Insider | Financials
Location
1805 Moriah Woods Blvd.
Memphis, TN 38117
Phone: (901) 761-7000
Fax: (901) 763-7045
Email: info@responseoncology.com
Employees (last reported count): 298
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Healthcare Facilities
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 44%
·Institutional: 0% (1% of float)
(8 institutions)
·Net Inst. Selling: 666.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Response Oncology, Inc. is a comprehensive cancer management company. The Company provides advanced cancer treatment services through outpatient facilities, known as Impact Centers, under the direction of practicing oncologists; owns the assets of and manages the non-medical aspects of oncology practices; compounds and dispenses pharmaceuticals to certain oncologists for a fixed or cost plus fee, and conducts outcomes research on behalf of pharmaceutical manufacturers. Approximately 300 medical oncologists are associated with the Company through these programs. On March 29, 2001, the Company and its wholly owned subsidiaries, Response Oncology Management of South Florida, Inc., Response Oncology of Fort Lauderdale, Inc. and Response Oncology of Tamarac, Inc., filed voluntary petitions for reorganization under Chapter 11 of the United States Bankruptcy Code.
More from Market Guide: Expanded Business Description

Financial Summary
ROIX is a comprehensive cancer management company that provides advanced cancer treatment services, manages the practices of oncologists, and conducts cancer research on behalf of pharmaceutical companies. For the six months ended 6/30/01, revenues fell 11% to $62.5 million. Net loss totaled $2.1 million, up from $416 thousand. Results reflect the termination of a certain Service Agreement and increased legal, accounting and reorganization expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

William West, M.D., 53
Chairman
--  
Anthony LaMacchia, 47
Pres, CEO, Director
$479K
Frank Bumstead, 59
Vice Chairman
--  
Peter Stark
CFO, Exec. VP
179K
Patrick McDonough
COO, Exec. VP
193K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ROIX.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Mar-2001
$0.03 
Recent Price$0.065
52-Week High
on 1-Sep-2000
$1.125
Beta1.78 
Daily Volume (3-month avg)16.1K
Daily Volume (10-day avg)4,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-93.9%
52-Week Change
relative to S&P500
-91.8%
Share-Related Items
Market Capitalization$799.0K
Shares Outstanding12.3M
Float6.90M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 5 on 3-Nov-1995
Per-Share Data
Book Value (mrq)$2.54 
Earnings (ttm)-$1.31 
Earnings (mrq)-$0.07 
Sales (ttm)$10.01 
Cash (mrq)$0.76 
Valuation Ratios
Price/Book (mrq)0.03 
Price/EarningsN/A 
Price/Sales (ttm)0.01 
Income Statements
Sales (ttm)$123.1M
EBITDA (ttm)-$16.4M
Income available to common (ttm)-$16.1M
Profitability
Profit Margin (ttm)-13.1%
Operating Margin (ttm)-19.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-16.36%
Return on Equity (ttm)-42.22%
Financial Strength
Current Ratio (mrq)1.25 
Debt/Equity (mrq)0.93 
Total Cash (mrq)$9.31M
Short Interest
As of 9-Mar-2001
Shares Short35.0K
Percent of Float0.5%
Shares Short
(Prior Month)
30.0K
Short Ratio0.43 
Daily Volume82.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.